Skip to main content
Erschienen in: World Journal of Urology 7/2018

05.03.2018 | Original Article

Quantitation of hypoechoic lesions for the prediction and Gleason grading of prostate cancer: a prospective study

verfasst von: Kwang Suk Lee, Kyo Chul Koo, Byung Ha Chung

Erschienen in: World Journal of Urology | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Hypoechoic lesions are not included as indicators for prostate biopsy. To discriminate the features of hypoechoic lesions, we investigated the ultrasonographic characteristics of hypoechoic lesions using numerical analysis in image. In addition, we evaluated previously suggested subjective parameters on hypoechoic lesion.

Methods

We performed one-core targeted biopsy (TBx) for each hypoechoic lesion in up to two lesions in each patient before the 12-core systemic biopsy was obtained between July 2015 and May 2016. Image analysis data were analyzed using grayscale values and Hounsfield units (HU) to measure heterogeneity. Subjective evaluation of hypoechoic lesions including hypoechoicity, irregularity, vascularity, and microcalcification was also validated.

Results

Of 157 patients (median age = 67.1 years, median prostate-specific antigen = 6.21 ng/mL) included in the study, 77 (49.0%) were diagnosed with prostate cancer (PCa), and 39 (17.0%) diagnoses were confirmed by the results of targeted cores. The existence of hypoechoic lesions was not a final predictor for PCa detection. In multivariate analysis using a combination of clinical and quantitative image analyses, the grayscale value was identified as a significant predictive factor for the presence of PCa and high-grade disease (Gleason score ≥ 7) on target lesions. The combination of clinical and image variables had the highest area under the curve (0.890) for detecting PCa in TBx.

Conclusions

The proposed method for the quantitation of hypoechoic lesions using grayscale images and HU is simple. Combined with the current clinical approaches, quantitative scoring of lesions can be useful for detecting PCa and making more precise diagnoses.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Carroll PR, Parsons JK, Andriole G et al (2016) NCCN guidelines insights: prostate cancer early detection, version 2.2016. J Natl Compr Cancer Netw 14:509–519CrossRef Carroll PR, Parsons JK, Andriole G et al (2016) NCCN guidelines insights: prostate cancer early detection, version 2.2016. J Natl Compr Cancer Netw 14:509–519CrossRef
5.
Zurück zum Zitat Salo JO, Rannikko S, Makinen J, Lehtonen T (1987) Echogenic structure of prostatic cancer imaged on radical prostatectomy specimens. Prostate 10:1–9CrossRefPubMed Salo JO, Rannikko S, Makinen J, Lehtonen T (1987) Echogenic structure of prostatic cancer imaged on radical prostatectomy specimens. Prostate 10:1–9CrossRefPubMed
8.
Zurück zum Zitat Hodge KK, McNeal JE, Terris MK, Stamey TA (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71–74 (discussion 74–75) CrossRefPubMed Hodge KK, McNeal JE, Terris MK, Stamey TA (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71–74 (discussion 74–75) CrossRefPubMed
10.
Zurück zum Zitat Strohmeyer D, Rossing C, Strauss F, Bauerfeind A, Kaufmann O, Loening S (2000) Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer. Prostate 42:26–33CrossRefPubMed Strohmeyer D, Rossing C, Strauss F, Bauerfeind A, Kaufmann O, Loening S (2000) Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer. Prostate 42:26–33CrossRefPubMed
11.
Zurück zum Zitat Muldoon L, Resnick MI (1989) Results of ultrasonography of the prostate. Urol Clin North Am 16:693–702PubMed Muldoon L, Resnick MI (1989) Results of ultrasonography of the prostate. Urol Clin North Am 16:693–702PubMed
12.
Zurück zum Zitat Vallancien G, Prapotnich D, Veillon B, Brisset JM, Andre-Bougaran J (1991) Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. J Urol 146:1308–1312CrossRefPubMed Vallancien G, Prapotnich D, Veillon B, Brisset JM, Andre-Bougaran J (1991) Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. J Urol 146:1308–1312CrossRefPubMed
13.
Zurück zum Zitat Hammerer P, Huland H (1994) Systematic sextant biopsies in 651 patients referred for prostate evaluation. J Urol 151:99–102CrossRefPubMed Hammerer P, Huland H (1994) Systematic sextant biopsies in 651 patients referred for prostate evaluation. J Urol 151:99–102CrossRefPubMed
15.
Zurück zum Zitat Li XG, Zhang DX, Cui XG et al (2012) Evaluating the oncologic outcomes in 152 patients undergoing extraperitoneal laparoscopic radical prostatectomy. Chin Med J (Engl) 125:1529–1535 Li XG, Zhang DX, Cui XG et al (2012) Evaluating the oncologic outcomes in 152 patients undergoing extraperitoneal laparoscopic radical prostatectomy. Chin Med J (Engl) 125:1529–1535
16.
Zurück zum Zitat Egawa S, Suyama K, Arai Y et al (2001) Treatment outcome by risk group after radical prostatectomy in Japanese men. Int J Urol 8:295–300CrossRefPubMed Egawa S, Suyama K, Arai Y et al (2001) Treatment outcome by risk group after radical prostatectomy in Japanese men. Int J Urol 8:295–300CrossRefPubMed
17.
Zurück zum Zitat Van Houten M, Gooren LJ (2000) Differences in reproductive endocrinology between Asian men and Caucasian men—a literature review. Asian J Androl 2:13–20PubMed Van Houten M, Gooren LJ (2000) Differences in reproductive endocrinology between Asian men and Caucasian men—a literature review. Asian J Androl 2:13–20PubMed
18.
Zurück zum Zitat Lee DH, Koo KC, Lee SH et al (2013) Low-risk prostate cancer patients without visible tumor (T1c) on multiparametric MRI could qualify for active surveillance candidate even if they did not meet inclusion criteria of active surveillance protocol. Jpn J Clin Oncol 43:553–558. https://doi.org/10.1093/jjco/hyt041 CrossRefPubMed Lee DH, Koo KC, Lee SH et al (2013) Low-risk prostate cancer patients without visible tumor (T1c) on multiparametric MRI could qualify for active surveillance candidate even if they did not meet inclusion criteria of active surveillance protocol. Jpn J Clin Oncol 43:553–558. https://​doi.​org/​10.​1093/​jjco/​hyt041 CrossRefPubMed
22.
Zurück zum Zitat Erbersdobler A, Fritz H, Schnoger S et al (2002) Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zone. Eur Urol 41:40–46CrossRefPubMed Erbersdobler A, Fritz H, Schnoger S et al (2002) Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zone. Eur Urol 41:40–46CrossRefPubMed
24.
Zurück zum Zitat Kravchick S, Cytron S, Peled R, Altshuler A, Ben-Dor D (2003) Using gray-scale and two different techniques of color Doppler sonography to detect prostate cancer. Urology 61:977–981CrossRefPubMed Kravchick S, Cytron S, Peled R, Altshuler A, Ben-Dor D (2003) Using gray-scale and two different techniques of color Doppler sonography to detect prostate cancer. Urology 61:977–981CrossRefPubMed
Metadaten
Titel
Quantitation of hypoechoic lesions for the prediction and Gleason grading of prostate cancer: a prospective study
verfasst von
Kwang Suk Lee
Kyo Chul Koo
Byung Ha Chung
Publikationsdatum
05.03.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 7/2018
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-018-2224-8

Weitere Artikel der Ausgabe 7/2018

World Journal of Urology 7/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.